NCT05936268View on ClinicalTrials.gov

Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare

PHASE2CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

July 21, 2023

Primary Completion Date

February 28, 2024

Study Completion Date

February 28, 2024

Conditions
Acute GoutGout Flare
Interventions
DRUG

Genakumab for injection

150 mg/1ml/bottle

DRUG

Colchicine

0.5mg/table

Trial Locations (1)

200030

Fudan University Affiliated Huashan Hospital, Shanghai

All Listed Sponsors
collaborator

Huashan Hospital

OTHER

lead

Changchun GeneScience Pharmaceutical Co., Ltd.

INDUSTRY

NCT05936268 - Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare | Biotech Hunter | Biotech Hunter